// App-Quantinova.ai

3408 : Bleeding Risk in Thrombocytopenic Cancer Patients with Venous Thromboembolism (VTE) Receiving Anticoagulation

Researchers

Presenter

  • Shuju Feng

Principal Investigators

  • Michael H. Kroll

  • Vahid Afshar-Kharghan

  • Thein H Oo

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Venous thrombosis

  • Intracerebral hemorrhage

  • Thrombocytopenia

  • Myelodysplastic Syndrome

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • Fondaparinux sodium

  • dalteparin Subcutaneous

  • Enoxaparin

  • Enoxaparin sodium

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved